- Home
- EXEL vs SJM Comparison
EXEL vs SJM Comparison
Compare EXEL & SJM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | SJM |
|---|---|---|
| Founded | 1994 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 11.2B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXEL | SJM |
|---|---|---|
| Price | $44.47 | $102.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 13 |
| Target Price | $45.45 | ★ $114.25 |
| AVG Volume (30 Days) | ★ 2.2M | 1.4M |
| Earning Date | 02-10-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 4.29% |
| EPS Growth | ★ 53.55 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | $2,288,218,000.00 | ★ $8,773,200,000.00 |
| Revenue This Year | $9.74 | $4.92 |
| Revenue Next Year | $12.27 | $2.20 |
| P/E Ratio | $18.63 | ★ N/A |
| Revenue Growth | ★ 9.93 | N/A |
| 52 Week Low | $31.90 | $93.30 |
| 52 Week High | $49.62 | $121.48 |
Technical Indicators
Market Signals| Indicator | EXEL | SJM |
|---|---|---|
| Relative Strength Index (RSI) | 52.18 | 54.56 |
| Support Level | $43.00 | $100.67 |
| Resistance Level | $45.41 | $104.36 |
| Average True Range (ATR) | 1.65 | 2.33 |
| MACD | -0.09 | 0.50 |
| Stochastic Oscillator | 58.22 | 72.16 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About SJM The J.M. Smucker Company
J.M. Smucker is a packaged food company that primarily sells through the US retail channel (73% of fiscal 2025 revenue came through its retail pet foods, coffee, and frozen handheld/spreads segments), with the remaining share consisting of sweet baked snacks (through the Hostess acquisition) and international (primarily Canada). Retail coffee is its largest category (32% of sales) with brands Folgers and Dunkin'. Pet foods (19% of sales) holds leading brands like Milk-Bone and Meow Mix. Of its remaining, approximately 22% comes from frozen handhelds and spreads, through brands Jif, Smucker's, and Uncrustables. The company acquired Hostess Brands in fiscal 2024 to boost its snack and convenience store presence.